Owkin will bring its world-class data access and AI to the forefront of drug discovery and development, analysing multimodal patient data in a privacy-enhanced...
Owkin, the first end-to-end TechBio unicorn that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, has unveiled an innovative drug...
Bioptimus will connect the different scales of biology with generative AI; from molecules to cells, tissues and whole organisms, to fuel scientific breakthroughs and...
Owkin, a TechBio that combines the best of human and artificial intelligence to find the right treatment for every patient, announced they are working...
Owkin, a French-American biotechnology company that applies artificial intelligence (AI) to drug discovery, development, and diagnostics, announced that it has entered into a collaboration...